HiberGene Diagnostics Ltd
HiberGene Diagnostics Limited develops, manufactures and markets molecular diagnostictests for human infectious diseases using a technology known as loop-mediated isothermalamplification (LAMP). HiberGene is committed to providing rapid and highly accurate testingsolutions, which are cost effective and simple to use. HiberGene’s product portfolio currentlycomprises CE-marked, singleplex molecular tests for Meningococcus, Group B Streptococcus,C. difficile and Mycoplasma pneumoniae and duplex tests for Meningococcus/Pneumococcus,CT/NG, Flu A/B and RSV A/B.HiberGene’s molecular tests are incubated and read on the HG Swift analyser. HiberGene’stests enable direct detection of bacteria or viruses from non-invasive human samples (e.g.swabs), with minimal sample processing. They provide clinicians with clinically critical, realtime results in less than 60 minutes, allowing for more effective management and treatment of patients with life-threatening infections.